These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14769233)

  • 1. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M; Surana R; Sankar C; Mishra B
    Acta Pharm; 2003 Dec; 53(4):263-73. PubMed ID: 14769233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and biopharmaceutical evaluation of osmotic matrix tablets of diclofenac sodium.
    Rani M; Surana R; Sankar C; Mishra B
    Drug Deliv; 2004; 11(4):263-70. PubMed ID: 15371108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M; Mishra B
    AAPS PharmSciTech; 2004 Aug; 5(4):e71. PubMed ID: 15760068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
    Alsarra IA
    Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
    Kshirsagar SJ; Bhalekar MR; Umap RR
    Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium.
    Fu J; Wang X; Xu L; Meng J; Weng Y; Li G; He H; Tang X
    Int J Pharm; 2011 Mar; 406(1-2):84-90. PubMed ID: 21219996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers.
    Hu L; Li L; Yang X; Liu W; Yang J; Jia Y; Shang C; Xu H
    Eur J Pharm Sci; 2011 Jan; 42(1-2):99-105. PubMed ID: 21050887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability.
    He H; Li H; Tang X
    Pharm Dev Technol; 2011 Jun; 16(3):212-8. PubMed ID: 20151942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers.
    Kienzler JL; Gold M; Nollevaux F
    J Clin Pharmacol; 2010 Jan; 50(1):50-61. PubMed ID: 19841157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
    Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
    Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled porosity osmotic pump system for the delivery of diclofenac sodium: in-vitro and in-vivo evaluation.
    Emara LH; Taha NF; El-Ashmawy AA; Raslan HM; Mursi NM
    Pharm Dev Technol; 2014 Sep; 19(6):681-91. PubMed ID: 24320694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.